Cytokine-mediated induction of nitric oxide synthase (type II NOS) and cyclo-oxygenase (COX-2) in vascular smooth muscle cells

G. Carrier, Andreas Papapetropoulos, C. Snead, J. Catravas

Research output: Contribution to journalArticle

Abstract

Type II NOS and COX-2 are expressed after stimulation with proinflammatory cytokines in a variety of tissues including smooth muscle cells (SMC). It is still unclear whether: a) cytokine-mediated inflammation is attributed to the induction of type II NOS and/or COX-2, and b) the vascular actions of cytokines in inflammatory diseases are species and tissuedependent. In the present study we have tested the hypothesis that E. coli LPS, IL-1β, and TNFα selectively induce type II NOS or COX-2 in different human and animal vascular SMC. Type II NOS and COX-2 activity were assessed by cGMP and cAMP accumulation, respectively, over a 15 min period in the presence of phosphodiesterase inhibition. Passage six cultured human renal artery and pulmonary vein SMC incubated 5 hrs with LPS, IL-1β or TNF α did not express type II NOS activity. On the other hand, LPS and IL-1β caused a 150- to 156-fold increase in cGMP levels in passage three cultured rat aortic SMC. In contrast, human pulmonary vein SMC exposed to LPS, IL-1β, or TNFα expressed a significant level of COX-2 activity as indicated by a 2-5 fold increase in cAMP accumulation, whereas in rat aortic SMC, COX-2 was not expressed following treatment with these agents. These results suggest that the induction of type II NOS and COX-2 by cytokines in vascular smooth muscle is both species and cell type dependent. (Supported by HL-52958 and American Heart Assoc. Ga. Affiliate).

Original languageEnglish (US)
JournalFASEB Journal
Volume10
Issue number3
StatePublished - Dec 1 1996
Externally publishedYes

Fingerprint

Nitric Oxide Synthase Type II
prostaglandin synthase
Prostaglandin-Endoperoxide Synthases
Vascular Smooth Muscle
blood vessels
smooth muscle
myocytes
Smooth Muscle Myocytes
Muscle
cytokines
Cells
Cytokines
Interleukin-1
interleukin-1
Pulmonary Veins
Rats
lungs
Renal Veins
Phosphoric Diester Hydrolases
Renal Artery

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Cytokine-mediated induction of nitric oxide synthase (type II NOS) and cyclo-oxygenase (COX-2) in vascular smooth muscle cells. / Carrier, G.; Papapetropoulos, Andreas; Snead, C.; Catravas, J.

In: FASEB Journal, Vol. 10, No. 3, 01.12.1996.

Research output: Contribution to journalArticle

@article{6c55e1dc1eae4305aff83cb95e4d8b5a,
title = "Cytokine-mediated induction of nitric oxide synthase (type II NOS) and cyclo-oxygenase (COX-2) in vascular smooth muscle cells",
abstract = "Type II NOS and COX-2 are expressed after stimulation with proinflammatory cytokines in a variety of tissues including smooth muscle cells (SMC). It is still unclear whether: a) cytokine-mediated inflammation is attributed to the induction of type II NOS and/or COX-2, and b) the vascular actions of cytokines in inflammatory diseases are species and tissuedependent. In the present study we have tested the hypothesis that E. coli LPS, IL-1β, and TNFα selectively induce type II NOS or COX-2 in different human and animal vascular SMC. Type II NOS and COX-2 activity were assessed by cGMP and cAMP accumulation, respectively, over a 15 min period in the presence of phosphodiesterase inhibition. Passage six cultured human renal artery and pulmonary vein SMC incubated 5 hrs with LPS, IL-1β or TNF α did not express type II NOS activity. On the other hand, LPS and IL-1β caused a 150- to 156-fold increase in cGMP levels in passage three cultured rat aortic SMC. In contrast, human pulmonary vein SMC exposed to LPS, IL-1β, or TNFα expressed a significant level of COX-2 activity as indicated by a 2-5 fold increase in cAMP accumulation, whereas in rat aortic SMC, COX-2 was not expressed following treatment with these agents. These results suggest that the induction of type II NOS and COX-2 by cytokines in vascular smooth muscle is both species and cell type dependent. (Supported by HL-52958 and American Heart Assoc. Ga. Affiliate).",
author = "G. Carrier and Andreas Papapetropoulos and C. Snead and J. Catravas",
year = "1996",
month = "12",
day = "1",
language = "English (US)",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Cytokine-mediated induction of nitric oxide synthase (type II NOS) and cyclo-oxygenase (COX-2) in vascular smooth muscle cells

AU - Carrier, G.

AU - Papapetropoulos, Andreas

AU - Snead, C.

AU - Catravas, J.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Type II NOS and COX-2 are expressed after stimulation with proinflammatory cytokines in a variety of tissues including smooth muscle cells (SMC). It is still unclear whether: a) cytokine-mediated inflammation is attributed to the induction of type II NOS and/or COX-2, and b) the vascular actions of cytokines in inflammatory diseases are species and tissuedependent. In the present study we have tested the hypothesis that E. coli LPS, IL-1β, and TNFα selectively induce type II NOS or COX-2 in different human and animal vascular SMC. Type II NOS and COX-2 activity were assessed by cGMP and cAMP accumulation, respectively, over a 15 min period in the presence of phosphodiesterase inhibition. Passage six cultured human renal artery and pulmonary vein SMC incubated 5 hrs with LPS, IL-1β or TNF α did not express type II NOS activity. On the other hand, LPS and IL-1β caused a 150- to 156-fold increase in cGMP levels in passage three cultured rat aortic SMC. In contrast, human pulmonary vein SMC exposed to LPS, IL-1β, or TNFα expressed a significant level of COX-2 activity as indicated by a 2-5 fold increase in cAMP accumulation, whereas in rat aortic SMC, COX-2 was not expressed following treatment with these agents. These results suggest that the induction of type II NOS and COX-2 by cytokines in vascular smooth muscle is both species and cell type dependent. (Supported by HL-52958 and American Heart Assoc. Ga. Affiliate).

AB - Type II NOS and COX-2 are expressed after stimulation with proinflammatory cytokines in a variety of tissues including smooth muscle cells (SMC). It is still unclear whether: a) cytokine-mediated inflammation is attributed to the induction of type II NOS and/or COX-2, and b) the vascular actions of cytokines in inflammatory diseases are species and tissuedependent. In the present study we have tested the hypothesis that E. coli LPS, IL-1β, and TNFα selectively induce type II NOS or COX-2 in different human and animal vascular SMC. Type II NOS and COX-2 activity were assessed by cGMP and cAMP accumulation, respectively, over a 15 min period in the presence of phosphodiesterase inhibition. Passage six cultured human renal artery and pulmonary vein SMC incubated 5 hrs with LPS, IL-1β or TNF α did not express type II NOS activity. On the other hand, LPS and IL-1β caused a 150- to 156-fold increase in cGMP levels in passage three cultured rat aortic SMC. In contrast, human pulmonary vein SMC exposed to LPS, IL-1β, or TNFα expressed a significant level of COX-2 activity as indicated by a 2-5 fold increase in cAMP accumulation, whereas in rat aortic SMC, COX-2 was not expressed following treatment with these agents. These results suggest that the induction of type II NOS and COX-2 by cytokines in vascular smooth muscle is both species and cell type dependent. (Supported by HL-52958 and American Heart Assoc. Ga. Affiliate).

UR - http://www.scopus.com/inward/record.url?scp=33749119532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749119532&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749119532

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -